eClinical Solutions A Technology that Help Accelerate the Clinical Development Process

eClinical Solutions

eClinical solutions help improve the clinical process through data management and analysis. It allows users to integrate, manage, analyze, and standardize clinical and operational data with integrated advanced visualization and analytical capabilities. eClinical S also manage clinical technologies and expertise to facilitate the acceleration of the clinical development. Moreover, eClinical sol are used to manage clinical trials and clinical research, as well as help maintain, track, manage, and record data/information.

Moreover, eClinical sol help researchers to efficiently organize, standardize, and manage their clinical research data and metadata during their research lifecycle. eClinical sol helps life sciences organizations around the world accelerate clinical development initiatives with expert data services and an elluminate Clinical Data Cloud, the foundation of digital trials. eClinical software allows users to analyze, manage, integrate, and standardize all their clinical and operational data with the help of integrated visualization and analytical capabilities.

The global eClinical Solutions Market was valued at US$ 3.5 billion in 2017 and is expected to witness a robust CAGR of 11.2% over the forecast period (2018 – 2026).

Moreover, some eClinical solutions help users to comply with government regulations, patient management, budgeting, investigator management, and adverse event reporting system among others. Originally, eClinical was used to refer to any involved technology, however, eClinical is a term used within the biopharma industry to refer to trial automation technology. They help transform the way clinical data integration, aggregation, and analytics. It provides end-to-end data management services and cloud-based products for clinical data optimization.

Therefore, the use of eClinical sol is increasing around the world, especially in the drug development process. For example, in January 2020, ERT announced an ERT record: 75% of compounds approved by U.S. FDA (Food and Drug Administration) in 2019 were developed using one or more of ERT’s eClinical sol during a drug development process. Moreover, ERT delivers innovative solutions that help biopharma companies meet global regulators’ strict guidelines for demonstrating the safety and efficacy of new medical compounds.

Comments

Popular posts from this blog

Wearable Injector are Devices Which Adhere to the Body and Help in Administering Drug to the Patient

Refinery Catalysts are Important Components of a Petroleum Refinery

Global Flocculant And Coagulant Market Is Estimated To Witness High Growth Owing To Increasing Demand For Water Treatment Applications